These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 29572291

  • 1. Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
    Park JK, Lee YJ, Shin K, Ha YJ, Lee EY, Song YW, Choi Y, Winthrop KL, Lee EB.
    Ann Rheum Dis; 2018 Jun; 77(6):898-904. PubMed ID: 29572291
    [Abstract] [Full Text] [Related]

  • 2. Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
    Park JK, Lee MA, Lee EY, Song YW, Choi Y, Winthrop KL, Lee EB.
    Ann Rheum Dis; 2017 Sep; 76(9):1559-1565. PubMed ID: 28468794
    [Abstract] [Full Text] [Related]

  • 3. A Multicenter, Prospective, Randomized, Parallel-Group Trial on the Effects of Temporary Methotrexate Discontinuation for One Week Versus Two Weeks on Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis.
    Park JK, Lee YJ, Shin K, Kang EH, Ha YJ, Park JW, Kim MJ, Kim MH, Choi SR, Jung Y, Lee JH, In Jung J, Kim JY, Winthrop KL, Lee EB.
    Arthritis Rheumatol; 2023 Feb; 75(2):171-177. PubMed ID: 35930728
    [Abstract] [Full Text] [Related]

  • 4. Effect of disease-modifying antirheumatic drug therapy on immune response to trivalent influenza vaccine in rheumatoid arthritis.
    Jain VK, Bhashini N, Balajee LK, Sistla S, Parija SC, Negi VS.
    Indian J Med Res; 2017 Apr; 145(4):464-470. PubMed ID: 28862177
    [Abstract] [Full Text] [Related]

  • 5. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.
    Kapetanovic MC, Saxne T, Nilsson JA, Geborek P.
    Rheumatology (Oxford); 2007 Apr; 46(4):608-11. PubMed ID: 17114801
    [Abstract] [Full Text] [Related]

  • 6. Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis.
    Mori S, Ueki Y, Hirakata N, Oribe M, Hidaka T, Oishi K.
    Ann Rheum Dis; 2012 Dec; 71(12):2006-10. PubMed ID: 22887851
    [Abstract] [Full Text] [Related]

  • 7. A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis.
    Subesinghe S, Bechman K, Rutherford AI, Goldblatt D, Galloway JB.
    J Rheumatol; 2018 Jun; 45(6):733-744. PubMed ID: 29545454
    [Abstract] [Full Text] [Related]

  • 8. Effect of short-term methotrexate discontinuation on rheumatoid arthritis disease activity: post-hoc analysis of two randomized trials.
    Park JK, Kim MJ, Choi Y, Winthrop K, Song YW, Lee EB.
    Clin Rheumatol; 2020 Feb; 39(2):375-379. PubMed ID: 31823141
    [Abstract] [Full Text] [Related]

  • 9. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
    Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, Wigler I, Balbir-Gurman A, Caspi D, Elkayam O.
    Ann Rheum Dis; 2008 Jul; 67(7):937-41. PubMed ID: 17981914
    [Abstract] [Full Text] [Related]

  • 10. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.
    Ribeiro AC, Guedes LK, Moraes JC, Saad CG, Aikawa NE, Calich AL, França IL, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky Mdo C, Precioso AR, Duarte A, Bonfa E, Laurindo IM.
    Ann Rheum Dis; 2011 Dec; 70(12):2144-7. PubMed ID: 21859696
    [Abstract] [Full Text] [Related]

  • 11. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
    van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, Blom M, Risselada AP, de Haan A, Westra J, Kallenberg CG, Bijl M.
    Arthritis Rheum; 2010 Jan; 62(1):75-81. PubMed ID: 20039396
    [Abstract] [Full Text] [Related]

  • 12. Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial.
    Park JK, Choi Y, Winthrop KL, Song YW, Lee EB.
    Ann Rheum Dis; 2019 Sep; 78(9):1283-1284. PubMed ID: 30904830
    [No Abstract] [Full Text] [Related]

  • 13. The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis.
    Winthrop KL, Silverfield J, Racewicz A, Neal J, Lee EB, Hrycaj P, Gomez-Reino J, Soma K, Mebus C, Wilkinson B, Hodge J, Fan H, Wang T, Bingham CO.
    Ann Rheum Dis; 2016 Apr; 75(4):687-95. PubMed ID: 25795907
    [Abstract] [Full Text] [Related]

  • 14. Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
    Kapetanovic MC, Kristensen LE, Saxne T, Aktas T, Mörner A, Geborek P.
    Arthritis Res Ther; 2014 Jan 02; 16(1):R2. PubMed ID: 24383620
    [Abstract] [Full Text] [Related]

  • 15. A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses.
    van de Witte S, Nauta J, Montomoli E, Weckx J.
    Vaccine; 2018 Sep 25; 36(40):6030-6038. PubMed ID: 29709447
    [Abstract] [Full Text] [Related]

  • 16. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
    Adler S, Krivine A, Weix J, Rozenberg F, Launay O, Huesler J, Guillevin L, Villiger PM.
    Rheumatology (Oxford); 2012 Apr 25; 51(4):695-700. PubMed ID: 22171015
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
    Kapetanovic MC, Nagel J, Nordström I, Saxne T, Geborek P, Rudin A.
    Vaccine; 2017 Feb 07; 35(6):903-908. PubMed ID: 28081972
    [Abstract] [Full Text] [Related]

  • 18. Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients.
    Westra J, van Assen S, Wilting KR, Land J, Horst G, de Haan A, Bijl M.
    Clin Exp Immunol; 2014 Oct 07; 178(1):40-7. PubMed ID: 24889761
    [Abstract] [Full Text] [Related]

  • 19. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF, Zhang AJ, To KK, Chan JF, Li P, Wong TL, Zhang R, Chan TC, Chan BC, Wai HH, Chan LW, Fong HP, Hui RK, Kong KL, Leung AC, Ngan AH, Tsang LW, Yeung AP, Yiu GC, Yung W, Lau JY, Chen H, Chan KH, Yuen KY.
    Lancet Infect Dis; 2016 Feb 07; 16(2):209-18. PubMed ID: 26559482
    [Abstract] [Full Text] [Related]

  • 20. Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
    Vesikari T, Kirstein J, Devota Go G, Leav B, Ruzycky ME, Isakov L, de Bruijn M, Oberye J, Heijnen E.
    Lancet Respir Med; 2018 May 07; 6(5):345-356. PubMed ID: 29631857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.